Arkolith/Insider Trading/QNCX

QNCX Insider Trading

Quince Therapeutics, Inc. · full profile →Last filing Jun 11, 2026

Quince Therapeutics, Inc. also files under CRTX; those filings are included.

Mixed · 180d
Open-Market Buys (180d)
$0
0 insiders
Open-Market Sells (180d)
$0
0 insiders
Net Insider Flow
$0
open market, 180d
Reporting Insiders
0
0 P/S transactions
Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp

Recent Form 4 Transactions

100 shown
DateInsiderRoleActionSharesPriceValue
Jun 11, 2026Senner Christopher J.DirectorGrant(A)3K—$0
Jun 11, 2026Lamond DavidDirectorGrant(A)3K—$0
May 18, 2026Roberts BrigetteChief Corp. Affairs Officer, DirectorGrant(A)134K——
May 18, 2026Roberts BrigetteChief Corp. Affairs Officer, DirectorGrant(A)229K——
May 18, 2026Roberts BrigetteChief Corp. Affairs Officer, DirectorGrant(A)362K——
May 18, 2026Roberts BrigetteChief Corp. Affairs Officer, DirectorGrant(A)6.8M——
May 18, 2026Roberts BrigetteChief Corp. Affairs Officer, DirectorGrant(A)69K——
May 18, 2026Roberts BrigetteChief Corp. Affairs Officer, DirectorGrant(A)125K——
May 18, 2026Roberts BrigetteChief Corp. Affairs Officer, DirectorGrant(A)6.8M——
May 18, 2026Roberts BrigetteChief Corp. Affairs Officer, DirectorGrant(A)35K——
May 18, 2026Roberts BrigetteChief Corp. Affairs Officer, DirectorGrant(A)2.1M——
Jan 23, 2026Hannah BrendanCBO, COO & CCOGrant(A)365K—$0
Jan 23, 2026Thye DirkCEO and CMO, DirectorGrant(A)1.0M—$0
Jan 23, 2026Ryan Charles S.PresidentGrant(A)200K—$0
Jan 2, 2026Lamond DavidDirectorGrant(A)29K—$0
Jan 2, 2026McLoughlin MargaretDirectorGrant(A)20K—$0
Jan 2, 2026Senner Christopher J.DirectorGrant(A)22K—$0
Jan 2, 2026Bray JuneDirectorGrant(A)19K—$0
Dec 26, 2025Benatti LucaDirectorSell(S)50K$3.47$174K
Dec 10, 2025Thye DirkCEO and CMO, DirectorGift(G)740K—$0
Dec 10, 2025Thye DirkCEO and CMO, DirectorGift(G)740K—$0
Dec 5, 2025Hannah BrendanCBO, COO & CCOOption exercise(M)2K—$0
Dec 5, 2025Hannah BrendanCBO, COO & CCOOption exercise(M)2K$0.55$1K
Dec 5, 2025Hannah BrendanCBO, COO & CCOOption exercise(M)25K$0.94$24K
Dec 5, 2025Hannah BrendanCBO, COO & CCOOption exercise(M)25K—$0
Jun 18, 2025Hannah BrendanCBO, COO & CCOGrant(A)38K$1.20$45K
Jun 18, 2025Thye DirkCEO and CMO, DirectorGrant(A)151K$0.13$20K
Jun 18, 2025Hannah BrendanCBO, COO & CCOGrant(A)38K$0.13$5K
Jun 18, 2025Thye DirkCEO and CMO, DirectorGrant(A)151K$1.20$181K
Jun 18, 2025Ryan Charles S.PresidentGrant(A)8K$0.13$981
Jun 18, 2025Ryan Charles S.PresidentGrant(A)8K$1.20$9K
Jun 4, 2025Benatti LucaDirectorGrant(A)27K—$0
Jun 4, 2025Lamond DavidDirectorGrant(A)27K—$0
Jun 4, 2025Senner Christopher J.DirectorGrant(A)27K—$0
Jun 4, 2025McLoughlin MargaretDirectorGrant(A)27K—$0
Jun 4, 2025Bray JuneDirectorGrant(A)27K—$0
Jun 4, 2025Patni RajivDirectorGrant(A)27K—$0
Jun 4, 2025Ryan Una SDirectorGrant(A)27K—$0
Jan 28, 2025Thye DirkCEO AND CHIEF MEDICAL OFFICER, DirectorGrant(A)1.2M—$0
Jan 28, 2025Ryan Charles S.PRESIDENTGrant(A)300K—$0
Jan 28, 2025Hannah BrendanCBO, COO and CCOGrant(A)450K—$0
Jan 2, 2025Bray JuneDirectorGrant(A)30K—$0
Jan 2, 2025McLoughlin MargaretDirectorGrant(A)32K—$0
Jan 2, 2025Senner Christopher J.DirectorGrant(A)35K—$0
Jan 2, 2025Lamond DavidDirectorGrant(A)48K—$0
Oct 23, 2024Benatti LucaDirectorOther(J)9K——
Aug 30, 2024Thye DirkCEO AND CHIEF MEDICAL OFFICER, DirectorBuy(P)77K$0.70$54K
Aug 29, 2024Thye DirkCEO AND CHIEF MEDICAL OFFICER, DirectorBuy(P)78K$0.69$53K
Aug 21, 2024Hannah BrendanCHIEF BUSINESS OFFICER AND COOBuy(P)24K$0.63$15K
Aug 21, 2024Hannah BrendanCHIEF BUSINESS OFFICER AND COOBuy(P)5K$0.62$3K
Aug 21, 2024Hannah BrendanCHIEF BUSINESS OFFICER AND COOBuy(P)2K$0.61$1K
Aug 20, 2024Hannah BrendanCHIEF BUSINESS OFFICER AND COOBuy(P)3K$0.61$2K
Aug 20, 2024Ryan Charles S.PRESIDENTBuy(P)48K$0.65$31K
Aug 20, 2024Hannah BrendanCHIEF BUSINESS OFFICER AND COOBuy(P)3K$0.60$2K
Aug 19, 2024Hannah BrendanCHIEF BUSINESS OFFICER AND COOBuy(P)2K$0.58$1K
Jun 5, 2024Ryan Una SDirectorGrant(A)27K—$0
Jun 5, 2024Senner Christopher J.DirectorGrant(A)27K—$0
Jun 5, 2024Bray JuneDirectorGrant(A)27K—$0
Jun 5, 2024Benatti LucaDirectorGrant(A)27K—$0
Jun 5, 2024Patni RajivDirectorGrant(A)14K—$0
Jun 5, 2024Lamond DavidDirectorGrant(A)27K—$0
Jun 5, 2024McLoughlin MargaretDirectorGrant(A)27K—$0
Jun 4, 2024Hannah BrendanCHIEF BUSINESS OFFICER AND COOOption exercise(M)56K—$0
Jun 4, 2024Hannah BrendanCHIEF BUSINESS OFFICER AND COOOption exercise(M)56K$0.55$31K
Feb 15, 2024Patni RajivDirectorGrant(A)54K—$0
Feb 1, 2024Ryan Charles S.PRESIDENTGrant(A)145K—$0
Feb 1, 2024Hannah BrendanCHIEF BUSINESS OFFICER AND COOGrant(A)600K—$0
Feb 1, 2024Thye DirkCEO AND CHIEF MEDICAL OFFICER, DirectorGrant(A)1.5M—$0
Jan 16, 2024Thye DirkCHIEF EXECUTIVE OFFICER, DirectorOption exercise(M)150K$0.94$141K
Jan 16, 2024Thye DirkCHIEF EXECUTIVE OFFICER, DirectorOption exercise(M)91K—$0
Jan 16, 2024Thye DirkCHIEF EXECUTIVE OFFICER, DirectorOption exercise(M)91K$0.55$50K
Jan 16, 2024Thye DirkCHIEF EXECUTIVE OFFICER, DirectorOption exercise(M)150K—$0
Dec 14, 2023Lamond DavidDirectorBuy(P)23K$1.04$24K
Dec 13, 2023Lamond DavidDirectorBuy(P)23K$1.00$23K
Dec 12, 2023Lamond DavidDirectorBuy(P)22K$1.02$23K
Dec 12, 2023Lamond DavidDirectorBuy(P)300$1.00$300
Dec 7, 2023Lamond DavidDirectorBuy(P)19K$1.01$19K
Dec 6, 2023Lamond DavidDirectorBuy(P)19K$1.02$20K
Dec 5, 2023Lamond DavidDirectorBuy(P)19K$1.01$19K
Dec 1, 2023Lamond DavidDirectorBuy(P)14K$0.94$14K
Nov 30, 2023Lamond DavidDirectorBuy(P)14K$0.90$13K
Nov 29, 2023Lamond DavidDirectorBuy(P)14K$0.98$14K
Oct 24, 2023Hannah BrendanChief Business Officer and COOGrant(A)75K—$0
Oct 23, 2023Janhofer GuenterChief Scientific OfficerGrant(A)300K—$0
Oct 23, 2023Benatti LucaDirectorGrant(A)54K—$0
Sep 1, 2023Ryan Charles S.PresidentGrant(A)545K—$0
Aug 31, 2023Lamond DavidDirectorBuy(P)41K$1.32$54K
Aug 30, 2023Lamond DavidDirectorBuy(P)41K$1.31$54K
Aug 17, 2023Lamond DavidDirectorBuy(P)25K$1.29$32K
Aug 16, 2023Lamond DavidDirectorBuy(P)117K$1.29$151K
Aug 15, 2023Lamond DavidDirectorBuy(P)108K$1.32$142K
Aug 10, 2023Thye DirkChief Executive Officer, DirectorBuy(P)88K$1.26$111K
Aug 8, 2023McLoughlin MargaretDirectorBuy(P)8K$1.23$10K
Aug 8, 2023Thye DirkChief Executive Officer, DirectorBuy(P)80K$1.24$99K
Aug 8, 2023Hannah BrendanChief Business OfficerBuy(P)72K$1.22$88K
May 24, 2023Senner Christopher J.DirectorGrant(A)27K—$0
May 24, 2023Ryan Una SDirectorGrant(A)27K—$0
May 24, 2023McLoughlin MargaretDirectorGrant(A)27K—$0
May 24, 2023Lamond DavidDirectorGrant(A)27K—$0
May 24, 2023Bray JuneDirectorGrant(A)27K—$0

Data Source

Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.

Issuer: Quince Therapeutics, Inc., SEC CIK 0001662774. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under QNCX and shows every filing by that issuer (also filed as CRTX).

Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-12. Earlier history is backfilling; this window widens as it deepens.

Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).

Keep exploring

Connected pages for QNCX